Found: 6
Select item for more details and to access through your institution.
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein.
- Published in:
- Nature Structural & Molecular Biology, 2009, v. 16, n. 11, p. 1134, doi. 10.1038/nsmb.1680
- By:
- Publication type:
- Article
SARS Coronavirus nsp1 Protein Induces Template-Dependent Endonucleolytic Cleavage of mRNAs: Viral mRNAs Are Resistant to nsp1-Induced RNA Cleavage.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 12, p. 1, doi. 10.1371/journal.ppat.1002433
- By:
- Publication type:
- Article
Engineering SARS-CoV-2 using a reverse genetic system.
- Published in:
- Nature Protocols, 2021, v. 16, n. 3, p. 1761, doi. 10.1038/s41596-021-00491-8
- By:
- Publication type:
- Article
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19055-7
- By:
- Publication type:
- Article
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 6, p. 1, doi. 10.1371/journal.ppat.1010627
- By:
- Publication type:
- Article